Abstract #2123

T2-Mapping as a Predictor for Non-Perfused Volume in MRgFUS Treatments of Desmoid Tumors

Eugene Ozhinsky¹, Matthew D. Bucknor¹, and Viola Rieke¹

¹Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States

Desmoid tumors are benign but locally aggressive soft tissue tumors that arise from fibroblast cells. Focused ultrasound has shown promising results in reduction of tumor volume without significant side effects. Post-treatment contrast enhanced MR imaging allows assessment of the non-perfused volume (NPV), the gold standard assessment of the quantity of tumor ablation. However, safety concerns regarding heating of tissue after gadolinium injection prevent further treatment following the NPV assessment. We have shown that T2 mapping can be used to visualize the extent of ablation with focused ultrasound and be used as a predictor of NPV without the need for contrast injections.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.